EDITORIALS Adjuvant Therapy for All Patients With Breast Cancer

[1]  F. Muggia,et al.  Re: Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes. , 2001, Journal of the National Cancer Institute.

[2]  C. Isaacs,et al.  New prognostic factors for breast cancer recurrence. , 2001, Seminars in oncology.

[3]  D. Hayes.  Do we need prognostic factors in nodal-negative breast cancer? Arbiter. , 2000, European journal of cancer.

[4]  Mike Clarke,et al.  Polychemotherapy for early breast cancer: an overview of the randomised trials , 1998, The Lancet.

[5]  Mike Clarke,et al.  Tamoxifen for early breast cancer: an overview of the randomised trials , 1998, The Lancet.

[6]  W. T. Sawyer,et al.  Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  P. Ravdin,et al.  Survey of breast cancer patients concerning their knowledge and expectations of adjuvant therapy. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.